With SARS-CoV-2 infections still spreading around the globe, we will soon be at a point where influenza and RSV infections will overlap with COVID-19. With that knowledge comes a number of questions: What might this mean for co-infections in both adults and children and how it might impact patient management? How does one distinguish these infections from each other and what role can testing play in this? Where do natural immunity, flu vaccines, and any potential COVID-19 vaccines fit in this equation?

Join us for a conversation with Dr. Manoj Gandhi, MD, PhD, Senior Medical Director for Genetic Testing Solutions at Thermo Fisher Scientific, to get his thoughts on what we may expect to see this coming Fall.